Clinical Trial Update: A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing induction therapies DA-90 vs DAC and salvage regimens FLAG-IDA vs CLAG-M in adults up to 60 with Acute Myeloid Leukemia; stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CLAG-M
• DA-90
• DAC
• FLAG-IDA

Snippet

Sponsor: Polish Adult Leukemia Group | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN